Brooklyn Immunotherapeutics Valuation
| BTXDelisted Stock | USD 0.21 0.01 5.00% |
Brooklyn Immunotherapeuti seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Brooklyn Immunotherapeuti from analyzing the firm fundamentals such as Return On Equity of -427.17, current valuation of (4.43 M), and Shares Owned By Insiders of 42.20 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Brooklyn Immunotherapeuti's price fluctuation is very steady at this time. Calculation of the real value of Brooklyn Immunotherapeuti is based on 3 months time horizon. Increasing Brooklyn Immunotherapeuti's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Brooklyn Immunotherapeutics is useful when determining the fair value of the Brooklyn stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Brooklyn Immunotherapeuti. Since Brooklyn Immunotherapeuti is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Brooklyn Stock. However, Brooklyn Immunotherapeuti's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.21 | Real 0.2 | Hype 0.21 |
The real value of Brooklyn Stock, also known as its intrinsic value, is the underlying worth of Brooklyn Immunotherapeuti Company, which is reflected in its stock price. It is based on Brooklyn Immunotherapeuti's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Brooklyn Immunotherapeuti's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Brooklyn Immunotherapeuti's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Brooklyn Immunotherapeutics helps investors to forecast how Brooklyn stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Brooklyn Immunotherapeuti more accurately as focusing exclusively on Brooklyn Immunotherapeuti's fundamentals will not take into account other important factors: Brooklyn Immunotherapeuti Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Brooklyn Immunotherapeuti's current stock value. Our valuation model uses many indicators to compare Brooklyn Immunotherapeuti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brooklyn Immunotherapeuti competition to find correlations between indicators driving Brooklyn Immunotherapeuti's intrinsic value. More Info.Brooklyn Immunotherapeutics is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies fabricating about 0.21 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Brooklyn Immunotherapeutics is roughly 4.84 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Brooklyn Immunotherapeuti by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Brooklyn Immunotherapeuti's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brooklyn Immunotherapeuti's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Brooklyn Immunotherapeuti's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Brooklyn Immunotherapeuti and how it compares across the competition.
About Brooklyn Immunotherapeuti Valuation
The delisted stock valuation mechanism determines the current worth of Brooklyn Immunotherapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Brooklyn Immunotherapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Brooklyn Immunotherapeuti based exclusively on its fundamental and basic technical indicators. By analyzing Brooklyn Immunotherapeuti's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Brooklyn Immunotherapeuti's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Brooklyn Immunotherapeuti. We calculate exposure to Brooklyn Immunotherapeuti's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Brooklyn Immunotherapeuti's related companies.Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York. Brooklyn ImmunoTherapeuti operates under Biotechnology classification in the United States and is traded on ASE Exchange. It employs 10 people.
8 Steps to conduct Brooklyn Immunotherapeuti's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Brooklyn Immunotherapeuti's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Brooklyn Immunotherapeuti's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Brooklyn Immunotherapeuti's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Brooklyn Immunotherapeuti's revenue streams: Identify Brooklyn Immunotherapeuti's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Brooklyn Immunotherapeuti's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Brooklyn Immunotherapeuti's growth potential: Evaluate Brooklyn Immunotherapeuti's management, business model, and growth potential.
- Determine Brooklyn Immunotherapeuti's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Brooklyn Immunotherapeuti's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Brooklyn Immunotherapeuti Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Brooklyn Immunotherapeuti does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Shares Percent Shares Out | 1.74% | |
| Forward Price Earnings | -0.43 | |
| Float Shares | 34.05M | |
| Shares Short Prior Month | 1.92M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Brooklyn Stock
If you are still planning to invest in Brooklyn Immunotherapeuti check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brooklyn Immunotherapeuti's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |